This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Global Radiopharmaceuticals Market Is Expected To Reach USD 12.2 Billion In 2018: Transparency Market Research

Related & Recently Published Reports by Transparency Market Research

http://www.transparencymarketresearch.com/insulin-market.html

http://www.transparencymarketresearch.com/us-vaccine-market.html

http://www.transparencymarketresearch.com/synthetic-biology-market.html

http://www.transparencymarketresearch.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market.html

http://www.transparencymarketresearch.com/asthma-and-copd-market.html

The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the radiopharmaceuticals market as below:

  • Radiopharmaceuticals Market by Generator Types
    • Mo-99/Tc-99m generator
    • Sr-82/Rb-82 generator
    • Ge-68/Ga-68 generator
    • Sr-90/ Y-90 generator
    • W-188/Re-188 generator
  • Radiopharmaceuticals Market by End-Users
    • Hospitals & Medical Centers
    • Diagnostic Centers
  • Radiopharmaceuticals Market by Applications
    • Diagnosis
      • Diagnosis by Technique
        • SPECT
          • Technetium (Tc-99m)
          • Thallium (TI-201)
          • Gallium (Ga-67)
          • Iodine (I-123)
          • Rhenium (Re-186)
          • Yttrium ( Y-90)
          •  Others
        • PET
          • Fludeoxyglucose (18F-FDG)
          • Rubidium (Rb-82)
          • Others ( Carbon-11 choline, Nitrogen-13 ammonia)
      • Diagnosis by Indications
        • Oncology
        • Cardiovascular
        • Others (Neurological, Thyroid, Gastrointestinal)
    • Therapy
      • Systemic Oncology
        • Iodine (I-131)
        • Yttrium (90Y)
        • Samarium (Sm-153)
        • Strontium (89Sr)
        • Rhenium (186Re)
        • Lutetium (Lu-177)
        • Erbium (169Er)
        • Others
      • Others (Cardiology, Neurology)
  • Radiopharmaceuticals Market by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Upcoming Reports in Pharmaceutical Market

Cell Based Assays Market

Drug Discovery Technologies Market

Sample Preparation In Genomics

Antibody Drugs Market

Treatments for Neurodegenerative Disorders

Polymerase Chain Reaction (PCR) Technologies

Radiopharmaceuticals Market

Preventive Healthcare Technologies, Products & Services Market

Kinase Inhibitors Market

Heparin Market

Theranostics Market

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with a highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,172.68 -107.06 -0.62%
S&P 500 1,994.29 -16.11 -0.80%
NASDAQ 4,527.6890 -52.10 -1.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs